A phase I open-label study to evaluate the safety of PROSTVAC-VF/TRICOM [prostate cancer vaccine] in the treatment of subjects with adenocarcinoma of the prostate
Phase of Trial: Phase I
Latest Information Update: 04 Sep 2012
At a glance
- Drugs Rilimogene galvacirepvec (Primary) ; Rilimogene glafolivec (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 06 Jan 2006 New trial record.